Background: In this prospective matched case-control study, hand movement analysis was conducted using a digitizing tablet (kinematical analysis). Methods: The study examined the association of different computer-assessed hand movement variables with clinical pathology (negative symptoms and extrapyramidal motor dysfunction). A sample of 16 schizophrenic patients and 16 healthy controls participated in the study. Results: At baseline, kinematical analysis indicated a significant higher prevalence of subtle hand motor dysfunction in unmedicated schizophrenic patients (who all exhibited clinically no extrapyramidal dysfunction) in comparison to healthy controls. No association between the observed motor signs and pre-enrollment total long-term butyrophenones exposure has been detected. After 14 days treatment with haloperidol, the hand movement variables, which correlated significantly with clinical rating scores reflecting drug-induced extrapyramidal dysfunction could definitely be separated from the hand movement variables with a close association to clinical rating measuring negative symptoms. Conclusions: Results of the comparative analysis at baseline confirm previous findings concerning presence of neurological soft signs in unmedicated schizophrenic patients. Furthermore, results of this pilot study suggest that kinematical analysis by means of a digitizing tablet could be a useful approach towards a differentiation between drug-induced akinetic symptoms and disease-induced negative symptoms.
References
1
Alexander G E, DeLong M R, Strick P L.
Parallel organization of functionally segregated circuits linking basal ganglia and cortex.
Annu Rev Neurosci.
1986;
9
357-381
2 American Psychiatric A ssociation. Diagnostic and Statistical Manual of Mental Disorders (4th edition) (DSM-IV). Washington, DC; American Psychiatric Association 1987
3
Browne S, Clarke M, Gervin M, Lane A, Waddington J L, Larkin C. et al .
Determinants of neurological dysfunction in first episode schizophrenia.
Psychol Med.
2000;
30
1433-1441
4
Buchanan R W, Kirkpatrick B, Heinrichs D W, Carpenter WT J r.
Clinical correlates of the deficit syndrome of schizophrenia.
Am J Psychiatry.
1990;
147
290-294
5
Chen E Y, Kwok C L, Au J W, Chen R Y, Lau B S.
Progressive deterioration of soft neurological signs in chronic schizophrenic patients.
Acta Psychiat Scand.
2000;
102
342-349
6
Chouinard G, Ross-Chouinard A, Annable L, Jones B D.
The Extrapyramidal Symptom Rating Scale.
Can J Neurol Sci.
1980;
7
233
7
Cunnington R, Bradshaw J L, Iansek R.
The role of the supplementary motor area in the control of voluntary movement.
Hum Mov Sci.
1996;
15
627-647
8
Eichhorn T, Gasser T, Mai N, Marquardt C, Arnold G, Schwarz J. et al .
Computational analysis of open loop handwriting movements in Parkinson's disease: a rapid method to detect dopamimetic effects.
Mov Disord.
1996;
11
289-297
9
Flyckt L, Borg J, Borg K, Ansved T, Edman G, Bjerkenstedt L. et al .
Muscle biopsy, macro EMG, and clinical characteristics in patients with schizophrenia.
Biol Psychiatry.
2000;
47
991-999
10
Gallucci R M, Phillips J G, Bradshaw J L, Vaddadi K S, Pantelis C.
Kinematic analysis of handwriting movements in schizophrenic patients.
Biol Psychiat.
1997;
41
830-833
11
Haase H J.
Über Vorkommen und Deutung des psychomotorischen Parkinsonsyndroms bei Megaphen- bzw. Largactil-Dauerbehandlung.
Nervenarzt.
1954;
25
486-492
12
Haase H J, Kaumeier S, Schwarz S, Gundel A, Linde O K, von Bomhard R H. et al .
Clinical trial of droperidol for the determination of the neuroleptic threshold and the neuroleptic-therapeutic range.
Int Pharmacopsychiatry.
1980;
15
74-80
13
Heinz A, Knable M B, Coppola R, Gorey J G, Jones D W, Lee K S. et al .
Psychomotor slowing, negative symptoms and dopamine receptor availability - an IBZM SPECT study in neuroleptic-treated and drug-free schizophrenic patients.
Schizophr Res.
1998;
31
19-26
14
Henkel V, Mergl R, Juckel G, Rujescu D, Mavrogiorgou P, Giegling I. et al .
Assessment of handedness using a digitizing tablet: a new method.
Neuropsychologia.
2001;
39
1158-1166
15
Jahn T, Cohen R, Mai N, Ehrensperger M, Marquardt C, Nitsche N. et al .
Untersuchung der fein- und grobmotorischen Dysdiadochokinese schizophrener Patienten: Methodenentwicklung und erste Ergebnisse einer computergestützten Mikroanalyse.
Zeitschr Klin Psychol.
1995;
24
300-315
16
Jahn T, Mussgay L.
Die statistische Kontrolle möglicher Medikamenteneinflüsse in experimentalpsychologischen Schizophreniestudien. Ein Vorschlag zur Berechnung von Chlorpromazinäquivalenten.
Zeitschr Klin Psychol.
1989;
18
257-267
17
Jogems-Kosterman B J, Zitman F G, van Hoof J J, Hulstijn W.
Psychomotor slowing and planning deficits in schizophrenia.
Schizophr Res.
2001;
48
317-333
18
Kay S R, Fiszbein A, Opler L A.
Positive and Negative Symptom Scale (PANSS) for schizophrenia.
Schizophr Bull.
1988;
13
21-76
19 Kraepelin E. Dementia Praecox and Paraphrenia. Edinburgh; Livingstone 1919
20 Marquardt C, Mai N. CS-Computerunterstützte Analyse der Bewegungsabläufe beim Schreiben. München; MedCom 1992
21
Marquardt C, Mai N.
A computational procedure for movement analysis in handwriting.
J Neurosci Methods.
1994;
52
39-45
22
Mergl R, Tigges P, Schröter A, Möller H -J, Hegerl U.
Digitized analysis of handwriting and drawing movements in healthy subjects. Methods, results and perspectives.
J Neurosci Methods.
1999;
90
157-169
23
Mori K, Yamashita H, Nagao M, Horiguchi J, Yamawaki S.
Effects of anticholinergic drug withdrawal on memory, regional cerebral blood flow and extrapyramidal side effects in schizophrenic patients.
Pharmacopsychiatry.
2002;
35
6-11
24
Peralta V, Cuesta M J.
Motor features in psychotic disorders. I: Factor structure and clinical correlates.
Schizophr Res.
2001;
47
107-116
25
Poyurovsky M, Nave R, Epstein R, Tzischinsky O, Schneidman M, Barnes T R. et al .
Actigraphic monitoring (actigraphy) of circadian locomotor activity in schizophrenic patients with acute neuroleptic-induced akathisia.
Eur Neuropsychopharmacol.
2000;
10
171-176
26
Sabbe B, Hulstijn W, van Hoof J JM, Tuynman-Qua H G, Zitman F.
Retardation in depression: assessment by means of simple motor tasks.
J Affect Disord.
1999;
55
39-44
27
Sabbe B, Hulstijn W, van Hoof J JM, Zitman F.
Fine motor retardation and depression.
J Psychiatry Res.
1996;
30
295-306
28
Schäfer M, Rujescu D, Giegling I, Guntermann A, Erfurth A, Bondy B. et al .
Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D(2) receptor gene.
Am J Psychiatry.
2001;
158
802-804
29
Schmidt K, Nolte-Zenker B, Patzer J, Bauer M, Schmidt L G, Heinz A.
Psychopathological correlates of reduced dopamine receptor sensitivity in depression, schizophrenia, and opiate and alcohol dependence.
Pharmacopsychiatry.
2001;
34
66-72
30
Schröder J, Essig M, Baudendistel K, Jahn T, Gerdsen I, Stockert A. et al .
Motor dysfunction and sensorimotor cortex activation changes in schizophrenia: A study with functional magnetic resonance imaging.
Neuroimage.
1999;
9
81-87
31
Schröder J, Wenz F, Schad L R, Baudendistel K, Knopp M V.
Sensorimotor cortex and supplementary motor area changes in schizophrenia. A study with functional magnetic resonance imaging.
Br J Psychiatry.
1995;
167
197-201
32
Shiffman S M, Gritz E R, Maltese J, Lee M A, Schneider N G, Jarvik M E.
Effects of cigarette smoking and oral nicotine on hand tremor.
Clin Pharmacol Ther.
1983;
33
800-805
33
Tigges P, Mergl R, Frodl T, Meisenzahl E M, Gallinat J, Schröter A. et al .
Digitized analysis of abnormal hand-motor performance in schizophrenic patients.
Schizophr Res.
2000;
45
133-143
34
Weinberger D R.
A connectionist approach to the prefrontal cortex.
J Neuropsychiatry Clin Neurosci.
1993;
5
241-253
35
World Medical A ssociation.
World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects.
JAMA.
1997;
277
925-926
Verena HenkelM.D.
Department of Psychiatry
Ludwig-Maximilians-University Munich
Nußbaumstr. 7
80336 Munich
Germany
Phone: +49/089-5160-5558
Fax: +49/089-5160-5542
Email: Verena.Henkel@psy.med.uni-muenchen.de